Progressive Supranuclear Palsy News and Research

RSS
Scientists develop selective therapy for tau tangles

Scientists develop selective therapy for tau tangles

Study reveals shared and unique molecular markers across multiple forms of dementia

Study reveals shared and unique molecular markers across multiple forms of dementia

Major trial to test multiple drugs for progressive supranuclear palsy

Major trial to test multiple drugs for progressive supranuclear palsy

New compound shows promise in Alzheimer’s preclinical models

New compound shows promise in Alzheimer’s preclinical models

NIH awards $6.9 million  to prepare a potential Alzheimer's treatment for future clinical trials

NIH awards $6.9 million to prepare a potential Alzheimer's treatment for future clinical trials

Protein biomarkers in spinal fluid offer promise for early progressive supranuclear palsy diagnosis

Protein biomarkers in spinal fluid offer promise for early progressive supranuclear palsy diagnosis

Blood test identifies specific pathologies in frontotemporal dementia, ALS, and PSP

Blood test identifies specific pathologies in frontotemporal dementia, ALS, and PSP

New treatments in sight for challenging neuropsychiatric symptoms in neurodegenerative diseases

New treatments in sight for challenging neuropsychiatric symptoms in neurodegenerative diseases

Innovative approach to disrupt misfolding of tau proteins in neurodegenerative diseases

Innovative approach to disrupt misfolding of tau proteins in neurodegenerative diseases

C-Path announces formation of new task force to foster drug development for Progressive Supranuclear Palsy

C-Path announces formation of new task force to foster drug development for Progressive Supranuclear Palsy

UVA Alzheimer's study pinpoints how tau protein damages brain cells

UVA Alzheimer's study pinpoints how tau protein damages brain cells

Redefining the battle against Alzheimer's with tau-focused treatments

Redefining the battle against Alzheimer's with tau-focused treatments

Wearable devices and machine learning revolutionize Parkinson's disease monitoring

Wearable devices and machine learning revolutionize Parkinson's disease monitoring

New tau PET radiotracer shows promise for early detection of Alzheimer's disease

New tau PET radiotracer shows promise for early detection of Alzheimer's disease

Decoding tauopathies: New study identifies non-coding RNA as a key player in Alzheimer's

Decoding tauopathies: New study identifies non-coding RNA as a key player in Alzheimer's

Penn Medicine researchers identify new therapeutic target for Alzheimer's disease

Penn Medicine researchers identify new therapeutic target for Alzheimer's disease

Researchers explore multi-syndrome prediction of dementia syndromes

Researchers explore multi-syndrome prediction of dementia syndromes

Targeting defective tau proteins may be needed to treat Alzheimer’s patients

Targeting defective tau proteins may be needed to treat Alzheimer’s patients

Possibility of the first fluid biomarker that reflects brain pathology in primary tauopathies

Possibility of the first fluid biomarker that reflects brain pathology in primary tauopathies

New biomarker can help identify people with a primary tauopathy

New biomarker can help identify people with a primary tauopathy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.